Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,210.00    90.00 (2.88%)
Bid:
3,085.00
Ask:
3,255.00
Spread: 170.00 (5.511%)
Market Cap: $843.15b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Transactions with Affiliated Companies

30 Apr 2025 08:42

RNS Number : 8064G
Samsung Electronics Co. Ld
30 April 2025
 

Transaction with Affiliate Company

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC"), on April 30, 2025, announced that its Board of Directors has authorized the following related-party transactions with affiliated companies.

 

1. Participation in rights offering

- Participation in the new stock issuance of Samsung SDI ("SDI")

Major transaction terms

Transaction items

2,284,590 common shares of SDI

Transaction date

May 22, 2025

Transaction value

KRW 334 billion (total invested capital of KRW 1,728.2 billion)

Purpose of transaction

To purchase new shares issued by SDI allotted to existing shareholders

Terms and conditions

* The transaction date is the subscription end date for existing shareholders.

* The transaction value is based on the issue price per share in SDI's new capital issue disclosure on April 9, 2025.

* The total invested capital is SEC's cumulative investment in SDI, including the transaction set forth herein.

* The terms above are subject to changes in the process of SDI's capital increase process.

Other Information:

Number of Independent Directors present at the Board of Directors meeting: 6Attendance of Audit Committee: Y

 

2. Purchase of Employee Insurance Policy from Samsung Fire & Marine Insurance

Major Transaction Terms

Insurer

Samsung Fire & Marine Insurance

Application date

May 2, 2025

Type of insurance

Employee insurance policy

Insurance premium

KRW 26.2 billion

Insurance period

May 2, 2025-May 2, 2028 (3 years)

Purpose of transaction

Insure eligible employees for unforeseen health costs, as part of the Company's employee welfare program

Method of insurance payment

Annual installment payment (3 years)

Other Information:

ž Number of Independent Directors present at the Board of Directors meeting: 6

ž Attendance of Audit Committee: Y

 

3. Investment in the New Technology Investment Association (SVIC 74)

- Investment in the New Technology Investment Association (SVIC 74), established by Samsung Venture Investment Corporation (SVIC).

Major transaction terms

Transaction date

May 2025

Transaction value

KRW 148.5 billion (to be made in cash)

Purpose of transaction

Discovery/acquisition of promising technologies for future readiness and reinforcement of business competitiveness in the DX division

Terms and conditions

* With the investment, SEC joins the New Technology Investment Association (SVIC 74).

* The total amount of the Investment Association (KRW 150 billion) is comprised of KRW 148.5 billion from SEC and KRW 1.5 billion from SVIC.

* The funds will be paid on an as-needed basis via investments over the 7-year term of SVIC 74. Both SEC's join date and duration of SVIC 74 are subject to change.

Other Information:

Number of Independent Directors present at the Board of Directors meeting: 6Attendance of Audit Committee: Y

 

This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must

 disclose financial and real estate transactions in the event the value of such a transaction is greater or

 equal to KRW 10 billion and the counterparty is an affiliate of the party required to make the disclosure.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGFDNGRGKZG
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.